跳至主要内容
临床试验/NCT02070575
NCT02070575已完成不适用

Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2014年2月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
profile of a panel of kallikrein related serine proteases in the blood

研究概览

简要总结

The purpose of this study is to investigate if a new blood test looking at PSA and a group of PSA related proteins in a patient's blood can indicate which men after surgery with a rising PSA could benefit from treatment, and/or indicate which men are at higher risk for recurrence before initial treatment is given.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • All patients treated with radical prostatectomy that develop a rising serum PSA ≥ 0.05ng/ml and have not received any kind of additional therapy.
  • Patients who have had additional therapy post radical prostatectomy are eligible for this study if ≥1 year has passed since treatment and the patient develops a rising serum PSA ≥0.05ng/ml.

排除标准

  • Previous additional therapy for prostate cancer, less than 1 year ago
  • No evidence of rising PSA
  • Patients unwilling to undergo venesection

结局指标

主要结局

profile of a panel of kallikrein related serine proteases in the blood

时间窗: 2 years

of patients that present with biochemical recurrence after radical prostatectomy.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验